Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study

OBJECTIVE: We aimed to understand the molecular pathways affected by bortezomib and arsenic trioxide treatment on myelomonocytoid cell line P39. MATERIALS AND METHODS: Oligonucleotide microarray platforms were used for gene expression and pathway analysis. Confirmation studies were performed using q...

Descripción completa

Detalles Bibliográficos
Autores principales: Savlı, Hakan, Galimberti, Sara, Sünnetçi, Deniz, Canestraro, Martina, Palumbo, Giuseppe, Nagy, Balint, Raimondo, Francesco Di, Petrini, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563195/
https://www.ncbi.nlm.nih.gov/pubmed/25913414
http://dx.doi.org/10.4274/tjh.2014.0058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563195/
https://www.ncbi.nlm.nih.gov/pubmed/25913414
http://dx.doi.org/10.4274/tjh.2014.0058

Ejemplares similares